PREGRIO-250
Hydroxyprogesterone Hexanoate 250 mg Injection
Product Technical Snapshot
Official pharmaceutical registration and manufacturing parameters
| Brand Name | PREGRIO-250 |
| Active Formulation (Salt) | Hydroxyprogesterone Hexanoate 250 mg Injection |
| Dosage Form | INJECTIONS |
| Packaging Presentation | Dispo |
| Therapeutic Category | INJECTIONS |
| Regulatory Classification | Schedule H Prescription Drug |
| Pharmacopoeial Standard | IP / BP / USP Pharmacopoeial Standards |
| Quality Certifications | WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility |
| Marketed & Distributed By | Riomedica Healthcare Pvt. Ltd. (Ambala Cantt & Panchkula, Haryana) |
| B2B Franchise Availability | Monopoly PCD Franchise rights available across all Indian districts |
What is PREGRIO-250?
Therapeutic monograph and clinical profile
PREGRIO-250 (Hydroxyprogesterone Hexanoate 250 mg Injection) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in Dispo, it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Reduces Preterm Birth Risk / Supports Pregnancy Maintenance.
Key Formulation Highlights
Why healthcare professionals recommend PREGRIO-250
Therapeutic Uses & Clinical Indications
Conditions and clinical disorders managed by this medicine
Recommended Clinical Indications:
Reduces Preterm Birth Risk / Supports Pregnancy Maintenance
Pharmacological Mechanism of Action
How PREGRIO-250 acts biochemically in the body
Delivers targeted active therapeutic release with rapid absorption and high safety profile.
Dosage & Administration Guidance
Proper usage directions under clinical supervision
As directed by the physician or healthcare professional. Take with water at prescribed intervals.
Precautions, Warnings & Contraindications
Safety guidelines and patient health considerations
Clinical Safety & Medical Advice:
Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.
Possible Side Effects
Tolerability profile and reporting
Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.
Storage & Handling Instructions
Maintaining formulation stability and shelf-life
Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.
Exclusive PCD Pharma Franchise Opportunity for PREGRIO-250
Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for PREGRIO-250 across India with comprehensive visual aids, prompt dispatch, and high profit margins.
Frequently Asked Questions (FAQs)
Common queries regarding PREGRIO-250
What is PREGRIO-250 used for?
What is the printed packaging and MRP of PREGRIO-250?
How can I get monopoly PCD franchise for PREGRIO-250?
Related Formulations in INJECTIONS
Explore complementary WHO-GMP certified healthcare formulations
